By the time you read this, Pfizer Inc. will be close to beginning distribution of its COVID-19 vaccine.
The scientific and medical community knows more now than it did at the beginning of the pandemic, and more data always is forthcoming. We will be better equipped to continue facing this in 2021.
With the year’s end, we present the State of the Industry report, where we asked our readers to weigh in on several topics, including physician burnout. In the survey results, 63.4% of respondents reported feeling symptoms of burnout (examples included exhaustion, reduced personal efficacy, and feelings of negativity or cynicism toward work). Further, 61.2% of respondents reported experiencing decreased career satisfaction.
In her presentation at the recent American College of Obstetricians and Gynecologists’ Annual Virtual Conference, Denise Jamieson, MD, MPH, reminded the audience that self-care, grace, and compassion are even more important now. “Everyone is under more stress at home and at work than what we are used to,” she said.
As you will see in the editorial from Editor-in-Chief Catherine Y. Spong, MD, this year has been particularly productive for Contemporary OB/GYN. We have so many people to thank, including Spong; our editorial board members, and peer reviewers. We also want to thank former board member Sharon T. Phelan, MD, for her keen insights, and long-time editorial consultant Judith M. Orvos, ELS, whose editorial prowess has helped this magazine be where it is today.
Take care of you and yours during this holiday season, and let’s look forward to 2021.
__
Mike Hennessy, Sr.
Chairman and Founder, MJH Life Sciences
Laparoscopic RFA linked to enhanced pregnancy outcomes in uterine fibroid patients
May 18th 2024A recent study presented at the 2024 ACOG Clinical and Scientific Meeting reveals that laparoscopic radiofrequency ablation significantly improves pregnancy outcomes for women with uterine leiomyomas.
Read More
Study reveals critical gaps in care for PCOS patients
May 17th 2024A new study presented at the 2024 ACOG Annual Clinical and Scientific Meeting highlighted significant gaps in polycystic ovary syndrome (PCOS) care, revealing widespread patient dissatisfaction and the urgent need for improved provider education and comprehensive treatment approaches.
Read More
OASIS-1 trial reports reduced VMS frequency and severity from elinzanetant
May 17th 2024A recent study showcased at the 2024 ACOG Annual Clinical & Scientific Meeting unveils elinzanetant's efficacy in alleviating vasomotor symptoms, sleep disturbances, and enhancing menopause-related quality of life in postmenopausal women.
Read More